Delivery Order SPE2DB22D2206-SPE2DB25FKC15
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Rifampin 150 mg capsules in quantities of 30 units. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $1,137.07 and an ultimate completion date of September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $1,069.22 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rifampin 150 mg capsules (30-count unit). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a single delivery order under the...
- The Defense Logistics Agency awarded a delivery order valued at $8,324.76 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) on September 15, 2025, with completion targeted for September 16, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,655.95 to AmerisourceBergen Drug Corp for the supply of Rifampin 300 mg capsules (60-count units) under a firm fixed price contract. The order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside competitive award represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $8,102.57. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Rifampin 300 mg capsules (60-count) with a ceiling value of $7,799.66. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $13,755.84. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's pharmaceutical supply services under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $1,020.97. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion on September 11, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Rifampin 300 mg capsules in unit dose packaging (100 count) under a firm fixed price contract valued at $3,300.54. This non-set-aside award is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's pharmaceutical supply support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,439.74 on August 14, 2025, for the supply of Rifampin 300 mg capsules (60-count units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 15, 2025, and performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FKC15Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Rifampin 300 mg capsules (60-count units) with a ceiling value of $4,160.15. This is a firm fixed-price delivery order with an ultimate completion date of September 25, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its headquarters and primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs globally, including specialty medications, generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. AmerisourceBergen Drug Corp has demonstrated capability to fulfill federal medical supply requirements through its extensive portfolio of competitive contract awards with the Defense Logistics Agency's Medical Supply Chain, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/24/25 |